GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
61.26
+5.11 (9.10%)
At close: Oct 26, 2026, 4:00 PM EDT
62.00
+0.74 (1.21%)
After-hours: Oct 26, 2026, 7:55 PM EDT

GeneDx Holdings Revenue

GeneDx Holdings had revenue of $114.44M in the quarter ending June 30, 2026, with 11.44% growth. This brings the company's total for the last twelve months to $454.43M, up 25.42% year-over-year. In the year 2025, GeneDx Holdings had annual revenue of $427.54M with 39.97% growth. That makes GeneDx Holdings the 11,764th largest company in the world by revenue and 2,346th in the United States.

Revenue (ttm)
$454.43M
Revenue Growth
+25.42%
P/S Ratio
4.02
Revenue / Employee
$349,558
Employees
1,300
Market Cap
1.83B

Revenue Chart

Revenue by Segment

  • Gene Dx 423.09M 99.0%
  • Fabric Genomics and Legacy Sema4 4.45M 1.0%
Fiscal year ended Dec 31, 2025 See the full GeneDx Holdings breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025427.54M122.09M39.97%
Dec 31, 2024305.45M102.88M50.79%
Dec 31, 2023202.57M-32.13M-13.69%
Dec 31, 2022234.69M22.50M10.60%
Dec 31, 2021212.20M32.87M18.33%
Dec 31, 2020179.32M-16.85M-8.59%
Dec 31, 2019196.17M62.83M47.12%
Dec 31, 2018133.34M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics806.60M
NeoGenomics766.30M
OPKO Health587.90M
Veracyte561.90M
CareDx458.09M
BillionToOne397.41M
Castle Biosciences357.28M
Fulgent Genetics323.93M
Revenue Rankings